The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 18, 2019
Filed:
Jan. 28, 2016
Applicant:
Biochemics, Inc., Danvers, MA (US);
Inventors:
Stephen G. Carter, Andover, MA (US);
Zhen Zhu, Andover, MA (US);
Kanu Patel, Londonderry, NH (US);
Diane L. Kozwich, Nottingham, NH (US);
Laura Stephens, Danvers, MA (US);
John J. Masiz, Topsfield, MA (US);
David H. Donabedian, Providence, RI (US);
Assignee:
BioChemics, Inc., Danvers, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 37/00 (2006.01); A61K 8/49 (2006.01); A61B 18/20 (2006.01); A61K 8/02 (2006.01); A61K 8/67 (2006.01); A61Q 1/14 (2006.01); A61Q 19/02 (2006.01); A61K 8/26 (2006.01); A61K 8/34 (2006.01); A61K 8/58 (2006.01); A61K 8/73 (2006.01); A61K 8/92 (2006.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01); A61N 1/32 (2006.01); A61N 5/06 (2006.01);
U.S. Cl.
CPC ...
A61K 8/4926 (2013.01); A61B 18/203 (2013.01); A61K 8/0208 (2013.01); A61K 8/26 (2013.01); A61K 8/342 (2013.01); A61K 8/498 (2013.01); A61K 8/585 (2013.01); A61K 8/678 (2013.01); A61K 8/73 (2013.01); A61K 8/922 (2013.01); A61Q 1/145 (2013.01); A61Q 19/02 (2013.01); A61B 2017/00769 (2013.01); A61B 2018/0047 (2013.01); A61B 2018/00452 (2013.01); A61K 2800/51 (2013.01); A61K 2800/74 (2013.01); A61K 2800/81 (2013.01); A61K 2800/91 (2013.01); A61M 37/0092 (2013.01); A61N 1/325 (2013.01); A61N 5/062 (2013.01);
Abstract
Methods and formulations for removing a tattoo by using a cell disrupter in combination with a vasodilator, and optionally one or more of an osmotic modifying agent, a chelation agent, and an occlusive modifying agent. Embodiments optionally further include using one or more of an antibiotic, anesthetic, penetration enhancer, excipient, carrier and vehicle.